Related Experiment Video
Updated: Mar 21, 2026

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection
Published on: July 21, 2022
Caspase-mediated DDX46 cleavage unchains antiviral immunity
Yanfeng Liu1, Zhongyuan Liu1, Xiaoqing Ou1
1Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Science, Shanghai, People's Republic of China.
Abstract:
DEAD/H-box RNA helicases are critical regulators of host antiviral innate immunity. In this study, we utilized an RNA-binding protein knockout sub-library to identify DDX46, a member of the DEAD/H-box RNA helicase family, as an essential proviral host factor for RNA virus replication. While DDX46 has been shown to sequester demethylated innate immune transcripts in the nucleus and dampen interferon (IFN) production, the mechanisms underlying its regulation during viral infection remain unclear. Here, we report that RNA virus infection induces caspase-dependent cleavage of DDX46, triggering its translocation from the nucleus to the cytoplasm. This translocation unchains innate immune transcripts from nuclear retention, licensing their rapid translation and potentiating robust IFN responses. Our findings reveal a novel regulatory mechanism by which post-translational modification and subcellular relocalization of DDX46 fine-tune the host antiviral response, highlighting the functional versatility of RNA helicases in host-virus interactions.IMPORTANCEUnderstanding how host cells regulate innate immune responses to viral infection is essential for developing effective antiviral strategies. Our study uncovers a critical role for caspase-dependent cleavage and nuclear-cytoplasmic translocation of DDX46 in promoting antiviral innate immunity. These findings not only expand our knowledge of the dynamic regulation of DEAD/H-box RNA helicases during infection but also suggest that targeting the post-translational modification and localization of such helicases may offer new avenues for antiviral therapeutic development.
Insights
RNA virus infection triggers DDX46 cleavage, moving it to the cytoplasm. This enhances the host antiviral innate immunity by allowing interferon production.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- DEAD/H-box RNA helicases regulate innate immunity.
- DDX46 sequesters immune transcripts, dampening interferon production.
- Regulation of DDX46 during viral infection is unclear.
Purpose of the Study:
- Identify host factors essential for RNA virus replication.
- Elucidate the regulatory mechanisms of DDX46 during viral infection.
- Investigate DDX46's role in host antiviral innate immunity.
Main Methods:
- Utilized an RNA-binding protein knockout sub-library.
- Investigated DDX46 cleavage and translocation.
- Assessed interferon production and transcript translation.
Main Results:
- Identified DDX46 as a proviral host factor.
- Demonstrated caspase-dependent cleavage of DDX46 upon viral infection.
- Showed DDX46 translocates from nucleus to cytoplasm, enhancing interferon responses.
- Revealed DDX46's role in licensing immune transcript translation.
Conclusions:
- RNA virus infection induces DDX46 cleavage and nuclear-cytoplasmic translocation.
- This process potentiates robust antiviral innate immunity.
- DDX46 post-translational modification and relocalization fine-tune host-virus interactions.
- Targeting DDX46 may offer new antiviral therapeutic strategies.
Related Concept Videos
Caspases
The Antiviral System of Bacteria and Archaea: CRISPR
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
The Extrinsic Apoptotic Pathway
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR/Cas9 Genome Editing

